Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "were"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Showing
1
-
20
of
266
Search:
'"were"'
,
query time: 0.03s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Pharmacoeconomic report: Vedolizumab (Entyvio SC) Takeda Canada Inc. : indication : for the treatment of adult patients with moderately to severely active ulcerative colitis who ha...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
2
Pharmacoeconomic report: Vedolizumab (Entyvio SC) Takeda Canada Inc. : indication : for the treatment of adult patients with moderately to severely active ulcerative colitis who ha...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
3
Pharmacoeconomic review report: Ustekinumab (Stelara/Stelara I.V.) Janssen Inc. : indication: treatment of adult patients with moderately to severely active ulcerative colitis who...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... of induction therapy, while the clinical criteria for the plaque psoriasis indication
were
: greater than 10...
”
Read Now
4
Clinical review report: Ustekinumab (Stelara/Stelara I.V.) Janssen Inc. : indication: treatment of adult patients with moderately to severely active ulcerative colitis who have had...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... with moderately to severely active ulcerative colitis who have failed or
were
intolerant to treatment...
”
Read Now
5
Clinical review report:: Vedolizumab (Entyvio SC) Takeda Canada Inc. : indication: for the treatment of adult patients with moderately to severely active ulcerative colitis who hav...
Published 2020
CADTH
“
... to severely active ulcerative colitis who have had an inadequate response to, loss of response to, or
were
...
”
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication : for the treatment of adult patients with moderately to severely acti...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... who have had an inadequate response or loss of response to, or who
were
intolerant to either...
”
Read Now
7
CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication : for the treatment of adult patients with moderately to severely acti...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... who have had an inadequate response or loss of response to, or who
were
intolerant to either...
”
Read Now
8
Second- and third-line pharmacotherapy for type 2 diabetes : update
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
...Since the original CADTH reports
were
published, interest has emerged in the combined use...
”
Read Now
9
Second- and third-line pharmacotherapy for type 2 diabetes : update
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
...Since the original CADTH reports
were
published, interest has emerged in the combined use...
”
Read Now
10
Second- and third-line pharmacotherapy for type 2 diabetes : update of CADTH 2010 reviews :project protocol
Published 2012
Canadian Agency for Drugs and Technologies in Health
“
...Since the original CADTH reports
were
published, interest has emerged in the combined use...
”
Read Now
11
Second- and third-line pharmacotherapy for type 2 diabetes : update of CADTH 2010 reviews :project protocol
Published 2012
Canadian Agency for Drugs and Technologies in Health
“
...Since the original CADTH reports
were
published, interest has emerged in the combined use...
”
Read Now
12
Pharmacoeconomic review report: Inotersen (Tegsedi) (Akcea Therapeutics, Inc.) : indication : stage I or II polyneuropathy in adults with hereditary transthyretin-mediated amyloido...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...Health-state utilities
were
further adjusted by treatment-specific time-dependent utilities based...
”
Read Now
13
Kidney transplantation following cardiocirculatory death : a review of the clinical evidence and guidelines
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
...,
were
unsuccessfully resuscitated, or critically ill patients who experienced unexpected cardiac arrest...
”
Read Now
14
Pharmacoeconomic review report: Inotersen (Tegsedi) (Akcea Therapeutics, Inc.) : indication : stage I or II polyneuropathy in adults with hereditary transthyretin-mediated amyloido...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...Health-state utilities
were
further adjusted by treatment-specific time-dependent utilities based...
”
Read Now
15
Pharmacoeconomic review report: Edoxaban (Lixiana)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
.... In addition, three concomitant events
were
incorporated to capture complications related to VTE: chronic...
”
Read Now
16
Pharmacoeconomic review report: Edoxaban (Lixiana)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
.... In addition, three concomitant events
were
incorporated to capture complications related to VTE: chronic...
”
Read Now
17
Pharmacoeconomic review report: Tafamidis (Vyndaqel) (Pfizer Canada ULC) : indication: for the treatment of adult patients with cardiomyopathy due to transthyretin-mediated amyloid...
Published 2020
CADTH
Read Now
18
Pharmacoeconomic review report: Vortioxetine hydrobromide (Trintellix) (Lundbeck Canada Inc.) : indication : the treatment of major depressive disorder in adults
Published 2020
CADTH
“
... for first-line treatment and short- and long-term AEs
were
assumed to occur over the first two-month cycle...
”
Read Now
19
Pharmacoeconomic review report: Tafamidis (Vyndaqel) (Pfizer Canada ULC) : indication: for the treatment of adult patients with cardiomyopathy due to transthyretin-mediated amyloid...
Published 2020
CADTH
Read Now
20
Pharmacoeconomic report: Onasemnogene abeparvovec (Zolgensma) : (Novartis Pharmaceuticals Canada Inc.) : indication: for the treatment of pediatric patients with 5q spinal muscular...
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
... of the SMN2 gene who
were
pre-symptomatic at baseline, but limitations within the clinical data informing...
”
1
2
3
4
5
6
7
8
9
10
11
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
610 - Medicine & health
166
330 - Economics
84
700 - The arts; fine & decorative arts
28
140 - Specific philosophical schools
21
580 - Plants (Botany)
9
100 - Philosophy & psychology
6
more ...
380 - Commerce, communications & transportation
4
400 - Language
2
612 - Human physiology
2
600 - Technology
1
see all ...
less ...
Language
English
266
Collection
National Center for Biotechnology Information
266
Author
Canadian Agency for Drugs and Technologies in Health
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
20
Argáez, Charlene
10
Ho, Chuong
9
Banerjee, Srabani
8
Loshak, Hannah
6
more ...
Tran, Khai
6
Wells, Charlotte
6
Brooker, Ann-Sylvia
4
De Angelis, Gino
4
Grobelna, Aleksandra
4
CADTH Canadian Drug Expert Committee
3
Cimon, Karen
3
Adams, Alison
2
Adcock, Lorna
2
Campbell, Kaitryn
2
Chao, Yi-Sheng
2
Dulong, Camille
2
Felipe, Eldiflor
2
Islam, Saadul
2
Jones, Sarah
2
Kaulback, Kellee
2
Kaunelis, David
2
Lachance, Chantelle
2
Li, Ke Xin
2
MacDonald, Erika
2
MacDougall, Danielle
2
Marchand, Dave K.
2
McCormack, Suzanne
2
Murphy, Gaetanne
2
Narain, Tasha
2
Perras, Christine
2
Rabb, Danielle
2
Richardson, Marina
2
Ryce, Andrea
2
Severn, Melissa
2
Spry, Carolyn
2
Subramonian, Anusree
2
Walter, Melissa
2
Wells, George A.
2
Williams, D.
2
Assasi, Nazila
1
Farrah, Kelly
1
Featherstone, Robin
1
Frey, Nina
1
Lau, Andrea
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&lookfor=%22were%22&type=AllFields
Send by Email
×
Loading...